0001014108-25-000065.txt : 20251022 0001014108-25-000065.hdr.sgml : 20251022 20251022170648 ACCESSION NUMBER: 0001014108-25-000065 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20251022 DATE AS OF CHANGE: 20251022 EFFECTIVENESS DATE: 20251022 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Bond Biosciences, Inc. CENTRAL INDEX KEY: 0001824224 ORGANIZATION NAME: EIN: 810933527 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-523360 FILM NUMBER: 251410793 BUSINESS ADDRESS: STREET 1: 555 MADISON AVENUE STREET 2: SUITE 1201 CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 650-804-2139 MAIL ADDRESS: STREET 1: 555 MADISON AVENUE STREET 2: SUITE 1201 CITY: NEW YORK STATE: NY ZIP: 10022 D/A 1 primary_doc.xml X0708 D/A LIVE 0001824224 Bond Biosciences, Inc. 170 English Landing Drive Suite 201B Parkville MO MISSOURI 64152 650-804-2139 DELAWARE Fetterex Biopharma, Inc. None Corporation true Michael A. Riley 170 English Landing Drive Suite 201B Parkville MO MISSOURI 64152 Executive Officer Director Cory Berkland 170 English Landing Drive Suite 201B Parkville MO MISSOURI 64152 Executive Officer Director Timothy Opler 170 English Landing Drive Suite 201B Parkville MO MISSOURI 64152 Director Michael Beckloff 170 English Landing Drive Suite 201B Parkville MO MISSOURI 64152 Director Other Health Care Decline to Disclose 06b true 0001014108-24-000043 2024-08-22 false true Simple Agreement for Future Equity false 0 Collage Venture Partners, LLC 316063 Stonehaven, LLC 118913 929 Alton Road Suite 500 Miami Beach FL FLORIDA 33139 AL ALABAMA CA CALIFORNIA CO COLORADO FL FLORIDA GA GEORGIA IL ILLINOIS IN INDIANA KS KANSAS ME MAINE MD MARYLAND MI MICHIGAN MO MISSOURI NJ NEW JERSEY NY NEW YORK NC NORTH CAROLINA PA PENNSYLVANIA TN TENNESSEE TX TEXAS UT UTAH WI WISCONSIN false 4500000 3815000 685000 false 83 267050 0 0 false Bond Biosciences, Inc. /s/Michael A. Riley Michael A. Riley Chief Executive Officer 2025-10-22